19. Personnel Expenses
The personnel expenses mentioned in “Note 17 Research and Development Expenses” and “Note 18 Selling, General and Administrative Expenses” above are as follows:
|
|
Year Ended December 31, |
||||
|---|---|---|---|---|---|---|
(in thousands of $) |
|
2025 |
|
2024 |
|
2023 |
Short‑term employee benefits – Salaries |
|
538,056 |
|
410,184 |
|
266,482 |
Short‑term employee benefits – Social Security |
|
39,086 |
|
30,856 |
|
19,231 |
Post‑employment benefits |
|
24,751 |
|
12,330 |
|
7,758 |
Termination benefits |
|
2,283 |
|
2,498 |
|
1,089 |
Share‑based payment |
|
238,493 |
|
228,142 |
|
226,830 |
Employer social security contributions |
|
46,418 |
|
51,898 |
|
7,987 |
Total personnel expenses |
|
889,087 |
|
735,908 |
|
529,377 |
The post-employment benefits relate to the pension plans the Company has in place for its employees.
The average number of full-time equivalents (FTE) by function is presented below:
|
|
Year Ended December 31, |
||||
|---|---|---|---|---|---|---|
Average Number of FTEs |
|
2025 |
|
2024 |
|
2023 |
Research and development |
|
1,003 |
|
805 |
|
607 |
Selling, general and administrative |
|
1,006 |
|
835 |
|
681 |
Total number of FTEs |
|
2,009 |
|
1,639 |
|
1,289 |